The immunomodulatory impacts of endocrine therapy on host immunity in early-stage hormone receptor positive, HER2 negative breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback